The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion
Status:
Completed
Trial end date:
2021-02-28
Target enrollment:
Participant gender:
Summary
This prospective non-randomized open-label interventional study aimed to evaluate feasibility
in regard to potential efficacy and safety of triamcinolone acetonide (TA) injected in the
suprachoroidal space (SCS) as a promising therapeutic route that provides a better
bioavailability, longer sustained duration of action, and thus improved patients' compliance
for the treatment of macular edema due to retinal vein occlusion (RVO).